(Citywire) Neil Woodford has attacked Kerrisdale Capital, the US hedge fund seeking to undermine one of the top holdings in the Woodford Patient Capital Trust (WPCT), saying its claims about Irish biotech company Prothena are ‘totally inaccurate and unsubstantiated.
Woodford Blasts US Hedge Fund Selling Prothena Short
This entry was posted in Syndicated. Bookmark the permalink.